1. Home
  2. NTRA vs CINF Comparison

NTRA vs CINF Comparison

Compare NTRA & CINF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • CINF
  • Stock Information
  • Founded
  • NTRA 2003
  • CINF 1950
  • Country
  • NTRA United States
  • CINF United States
  • Employees
  • NTRA N/A
  • CINF N/A
  • Industry
  • NTRA Medical Specialities
  • CINF Property-Casualty Insurers
  • Sector
  • NTRA Health Care
  • CINF Finance
  • Exchange
  • NTRA Nasdaq
  • CINF Nasdaq
  • Market Cap
  • NTRA 27.0B
  • CINF 24.2B
  • IPO Year
  • NTRA 2015
  • CINF N/A
  • Fundamental
  • Price
  • NTRA $214.45
  • CINF $162.47
  • Analyst Decision
  • NTRA Strong Buy
  • CINF Strong Buy
  • Analyst Count
  • NTRA 16
  • CINF 2
  • Target Price
  • NTRA $224.25
  • CINF $177.50
  • AVG Volume (30 Days)
  • NTRA 1.4M
  • CINF 577.7K
  • Earning Date
  • NTRA 11-06-2025
  • CINF 10-27-2025
  • Dividend Yield
  • NTRA N/A
  • CINF 2.14%
  • EPS Growth
  • NTRA N/A
  • CINF N/A
  • EPS
  • NTRA N/A
  • CINF 13.44
  • Revenue
  • NTRA $2,116,676,000.00
  • CINF $12,078,000,000.00
  • Revenue This Year
  • NTRA $25.70
  • CINF $4.42
  • Revenue Next Year
  • NTRA $15.42
  • CINF $3.70
  • P/E Ratio
  • NTRA N/A
  • CINF $12.08
  • Revenue Growth
  • NTRA 38.17
  • CINF N/A
  • 52 Week Low
  • NTRA $125.38
  • CINF $123.02
  • 52 Week High
  • NTRA $215.81
  • CINF $168.20
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 72.21
  • CINF 55.68
  • Support Level
  • NTRA $195.14
  • CINF $160.94
  • Resistance Level
  • NTRA $212.21
  • CINF $168.20
  • Average True Range (ATR)
  • NTRA 8.53
  • CINF 2.97
  • MACD
  • NTRA 0.30
  • CINF 0.36
  • Stochastic Oscillator
  • NTRA 96.18
  • CINF 67.68

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CINF Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The company operates in segments: Commercial lines insurance, Personal lines insurance, and Excess and surplus lines insurance, Life insurance, and Investments. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

Share on Social Networks: